Related references
Note: Only part of the references are listed.Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs
Michael C. Byrns et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Overexpression of Dihydrodiol Dehydrogenase as a Prognostic Marker in Resected Gastric Cancer Patients
Hung-Chi Chang et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
c-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse epidermal JB6 Cl41 cells
Dongyun Zhang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies
Michael C. Byrns et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Multi-targeted therapy of cancer by genistein
Sanjeev Banerjee et al.
CANCER LETTERS (2008)
MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells
Sangeeta Bafna et al.
CANCER RESEARCH (2008)
Induction of Cytoplasmic Accumulation of p53: A Mechanism for Low Levels of Arsenic Exposure to Predispose Cells for Malignant Transformation
Yelin Huang et al.
CANCER RESEARCH (2008)
PI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation
Weiming Ouyang et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2008)
Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2
Jingbo Pi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
The next innovation cycle in toxicogenomics: Environmental epigenetics
Stella Marie Reamon-Buettner et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Evidence for the aldo-keto reductase pathway of polycyclic aromatic trans-dihydrodiol activation in human lung A549 cells
Jong-Heum Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats
Takeki Uehara et al.
TOXICOLOGY (2008)
Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells
Jianli Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms
Trevor M. Penning et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2007)
Phytoestrogens as inhibitors of the human progesterone metabolizing enzyme AKR1C1
Petra Brozic et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer
Masatsugu Ueda et al.
GYNECOLOGIC ONCOLOGY (2006)
Induction of AKR1C2 by phase II inducers:: Identification of a distal consensus antioxidant response element regulated by NRF2
H Lou et al.
MOLECULAR PHARMACOLOGY (2006)
Aldo-keto reductase (AKR) 1C3: Role in prostate disease and the development of specific inhibitors
TM Penning et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2006)
Distinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolites
PS Su et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2006)
Increased expression of type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma
KM Fung et al.
ENDOCRINE-RELATED CANCER (2006)
Expression of dihydrodiol dehydrogenase plays important roles in apoptosis- and drug-resistance of A431 squamous cell carcinoma
KC Chow et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2006)
Inorganic arsenic compounds and methylated metabolites induce morphological transformation in two-stage BALB/c 3T3 cell assay and inhibit metabolic cooperation in V79 cell assay
T Tsuchiya et al.
TOXICOLOGICAL SCIENCES (2005)
Development of nonsteroidal anti-inflammatory drug analogs and steroid carboxylates selective for human aldo-keto reductase isoforms: Potential antineoplastic agents that work independently of cyclooxygenase isozymes
DR Bauman et al.
MOLECULAR PHARMACOLOGY (2005)
p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis
SP Hussain et al.
CANCER RESEARCH (2004)
Structure-function of human 3α-hydroxysteroid dehydrogenases:: genes and proteins
TM Penning et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Ubiquitous induction of resistance to platinum drugs in human ovarian, cervical, germ-cell and lung carcinoma tumor cells overexpressing isoforms 1 and 2 of dihydrodiol dehydrogenase
HB Deng et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Inverse expression of dihydrodiol dehydrogenase and glutathione-s-transferase in patients with esophageal squamous cell carcinoma
LS Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Oxidative mechanism of arsenic toxicity and carcinogenesis
HL Shi et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2004)
Association of chromosomal alterations with arsenite-induced tumorigenicity of human HaCaT Keratinocytes in nude mice
CW Chien et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2004)
Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
MJ Lewis et al.
BMC CANCER (2004)
The roles of aldo-keto reductases in steroid hormone action
DR Bauman et al.
DRUG NEWS & PERSPECTIVES (2004)
Human 20α-hydroxysteroid dehydrogenase:: Crystallographic and site-directed mutagenesis studies lead to the identification of an alternative binding site for C21-steroids
JF Couture et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
Selective reduction of AKR1C2 in prostate cancer and its role in DHT metabolism
Q Ji et al.
PROSTATE (2003)
Role of human type 3 3α-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells
TL Rizner et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2003)
Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide
JB Pi et al.
EXPERIMENTAL CELL RESEARCH (2003)
Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrations
K Mure et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2003)
Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells
NT Palackal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Incidence of transitional cell carcinoma and arsenic in drinking water: A follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan
HY Chiou et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction
W Ax et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
